Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
41	February 25, 2013 Astex Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results Reports Annual Net Income of $8.2 Million Dacogen Royalty Revenue Increases 17.5% from Prior Year Ends Year with $138 Mi Add to Reading List Source URL: astx.com Language: English Taxation Intellectual property law Generally Accepted Accounting Principles Financial statements Financial accounting Income tax in the United States Deferral Balance sheet Amortization Accountancy Finance Business
42	October 30, 2012 Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results Dacogen Approved in the European Union for the Treatment of Elderly AML Initiated HSP90 Inhibitor AT13387 Clinical Trials in Prostate & Add to Reading List Source URL: astx.com Language: English Generally Accepted Accounting Principles Taxation Financial statements Financial accounting Financial markets Balance sheet Income tax in the United States Deferral Income tax Finance Accountancy Business
43	September 21, 2012 Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedica Add to Reading List Source URL: astx.com Language: English Organic chemistry Alkynes Astex Small-cell carcinoma Clinical trial Homologous recombination Erlotinib Medicine Chemistry Lung cancer
44	January 2, 2013 Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasda Add to Reading List Source URL: astx.com Language: English Hepatology Hepatocellular carcinoma Sorafenib Myelodysplastic syndrome Acute myeloid leukemia Medicine Oncology Chemistry
45	January 16, 2013 Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to Treat Several Cancer Types DUBLIN, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX Add to Reading List Source URL: astx.com Language: English Cancer organizations Cancer research Association of Commonwealth Universities Institute of Cancer Research University of London Astex Cancer Research UK Abiraterone Medical research Medicine Health Oncology
46	October 24, 2012 Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu Add to Reading List Source URL: astx.com Language: English Organofluorides Piperidines Lung cancer Crizotinib Pyrazoles Anaplastic lymphoma kinase Non-small-cell lung carcinoma Hsp90 Erlotinib Chemistry Organic chemistry Pfizer
47	June 13, 2012 Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a phar Add to Reading List Source URL: astx.com Language: English Protein kinase inhibitor Drug discovery Pharmaceutical sciences Pharmacology Astex
48	Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012 DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and develop Add to Reading List Source URL: astx.com Language: English
49	Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL DUBLIN, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX - News), a pharmaceutical co Add to Reading List Source URL: astx.com Language: English Antiviral drug Allosteric regulation Astex Hepatitis C virus Proteins
50	July 10, 2012 Astex Board Member Wins 2012 European Mediscience Award DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and Add to Reading List Source URL: astx.com Language: English Astex Evotec Vernalis plc